Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FCC Chairman Sings MBAN Praises In Advance Of May 24 Spectrum Vote

This article was originally published in The Gray Sheet

Executive Summary

Julius Genachowski, chairman of the Federal Communications Commission, met May 17 with officials from GE Healthcare, Philips Healthcare and George Washington University Hospital to highlight the benefits of medical body area networks in improving care and reducing costs.

You may also be interested in...



FCC-Appointed Task Force Seeks Public-Private Input In Growing U.S. mHealth Market

An mHealth Task Force appointed by Federal Communications Commission Chairman Julius Genachowski released a draft report Sept. 24 outlining ways federal agencies and private industry can help spur the adoption of mHealth technologies.

MedTech’s Impact On Hospital Design Requires Early Planning, Communication, Stakeholders Say

Chief medical officers from Siemens and GE Healthcare tell “The Gray Sheet” how technological advances will change the way hospitals look over the next decade or two.

Medical Body Area Networks Get Go-Ahead From FCC

The Federal Communications Commission voted to approve MBAN spectrum May 24, and is now seeking public comments on how to designate an MBAN coordinator.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel